EA200701619A1 - Применение ингибиторов тирозинкиназы для лечения хронического риносинусита - Google Patents

Применение ингибиторов тирозинкиназы для лечения хронического риносинусита

Info

Publication number
EA200701619A1
EA200701619A1 EA200701619A EA200701619A EA200701619A1 EA 200701619 A1 EA200701619 A1 EA 200701619A1 EA 200701619 A EA200701619 A EA 200701619A EA 200701619 A EA200701619 A EA 200701619A EA 200701619 A1 EA200701619 A1 EA 200701619A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
inhibitors
thyrosinkinase
application
chronic rhinosinusitis
Prior art date
Application number
EA200701619A
Other languages
English (en)
Inventor
Биргит Юнг
Бернд Диссе
Геральд Поль
Original Assignee
Бёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36228798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200701619(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102005005505A external-priority patent/DE102005005505A1/de
Priority claimed from DE102005036216A external-priority patent/DE102005036216A1/de
Application filed by Бёрингер Ингельхайм Интернациональ Гмбх filed Critical Бёрингер Ингельхайм Интернациональ Гмбх
Publication of EA200701619A1 publication Critical patent/EA200701619A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

В заявке описано применение выбранных ингибиторов EGFR-киназы, прежде всего выбранных хиназолинов, хинолинов и пиримидопиримидинов, для лечения назального полипоза и хронического риносинусита.
EA200701619A 2005-02-04 2006-01-16 Применение ингибиторов тирозинкиназы для лечения хронического риносинусита EA200701619A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005005505A DE102005005505A1 (de) 2005-02-04 2005-02-04 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis
DE102005036216A DE102005036216A1 (de) 2005-08-02 2005-08-02 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis
PCT/EP2006/050215 WO2006082129A1 (de) 2005-02-04 2006-01-16 Verwendung von tyrosinkinase-inhibitoren zur behandlung der chronischen rhinosinusitis

Publications (1)

Publication Number Publication Date
EA200701619A1 true EA200701619A1 (ru) 2008-02-28

Family

ID=36228798

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701619A EA200701619A1 (ru) 2005-02-04 2006-01-16 Применение ингибиторов тирозинкиназы для лечения хронического риносинусита

Country Status (14)

Country Link
US (1) US20060178364A1 (ru)
EP (1) EP1845992A1 (ru)
JP (1) JP2009523700A (ru)
KR (1) KR20070108889A (ru)
AR (1) AR055029A1 (ru)
AU (1) AU2006210175A1 (ru)
BR (1) BRPI0607358A2 (ru)
CA (1) CA2601740A1 (ru)
EA (1) EA200701619A1 (ru)
IL (1) IL184997A0 (ru)
MX (1) MX2007009265A (ru)
NO (1) NO20073097L (ru)
TW (1) TW200638937A (ru)
WO (1) WO2006082129A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104166A1 (en) * 2008-01-18 2011-05-05 Stankovic Konstantina M Methods and Compositions for Treating Polyps
EP2346507A1 (en) * 2008-09-03 2011-07-27 Boehringer Ingelheim International GmbH Use of quinazoline derivatives for the treatment of viral diseases
CN102264745B (zh) 2008-11-10 2015-07-22 财团法人卫生研究院 作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物
CN104844580B (zh) * 2015-04-17 2017-10-20 中国药科大学 嘧啶类化合物、其制备方法及医药用途
US20170007704A1 (en) * 2015-07-09 2017-01-12 David Ram Carrier and pharmaceutical compositions for intrasinal delivery and uses thereof
MA46852A (fr) 2016-11-17 2019-09-25 Univ Texas Composés à activité antitumorale contre des cellules cancéreuses porteuses de mutations egfr ou her2 exon 20
RU2646806C1 (ru) * 2017-05-05 2018-03-07 Дмитрий Александрович Щербаков Способ лечения хронического полипозного риносинусита
KR20220057993A (ko) 2020-10-30 2022-05-09 오창민 코막힘, 콧물 등 알레르기 비염을 포함한 부비동 질환의 증상 개선을 위한 식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042062A1 (de) * 2000-08-26 2002-03-07 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Hertellung
DE10204462A1 (de) * 2002-02-05 2003-08-07 Boehringer Ingelheim Pharma Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
AU2003226705B2 (en) * 2002-03-30 2008-11-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
DE10334226A1 (de) * 2003-07-28 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
DE10350717A1 (de) * 2003-10-30 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse

Also Published As

Publication number Publication date
EP1845992A1 (de) 2007-10-24
AU2006210175A1 (en) 2006-08-10
JP2009523700A (ja) 2009-06-25
TW200638937A (en) 2006-11-16
IL184997A0 (en) 2007-12-03
CA2601740A1 (en) 2006-08-10
MX2007009265A (es) 2007-09-07
US20060178364A1 (en) 2006-08-10
WO2006082129A1 (de) 2006-08-10
KR20070108889A (ko) 2007-11-13
NO20073097L (no) 2007-07-12
AR055029A1 (es) 2007-08-01
BRPI0607358A2 (pt) 2009-09-01

Similar Documents

Publication Publication Date Title
EA200701619A1 (ru) Применение ингибиторов тирозинкиназы для лечения хронического риносинусита
EA200870410A1 (ru) Антагонисты киназы
EA200970738A1 (ru) Ингибиторы активности akt
DK1948180T3 (da) Kombinationsbehandling af cancer omfattende EGFR/HER2 inhibitorer
TW200801008A (en) Protein kinase inhibitors
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
ATE395346T1 (de) Chinazolinderivate als tyrosinkinaseinhibitoren
HN2005000477A (es) Compuestos de aminoheteroarilo sustituidos con piraol como inhibidores de proteina quinasa
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
WO2004100947A3 (en) Novel chemical compounds
EA200801430A1 (ru) Производные триазола
EA201170831A1 (ru) Аминопиразольное соединение
WO2007129226A3 (en) Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
NO20072179L (no) Kombinasjon av en SRC kinase inhibitor og en. BCR-ABL inhibitor for behandling av proleferative sykdommer
WO2008063558A3 (en) Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
DE602007004333D1 (de) Inhibitoren von akt (proteinkinase b)
ATE520664T1 (de) Tyrosinkinase-hemmer
NO20081292L (no) Pentasykliske kinaseinhibitorer
WO2007076320A3 (en) Compounds
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
ATE414706T1 (de) Pyridopyrazolopyrimidinderivate und ihre anwendung gegen krebs und diabetes
WO2009052379A3 (en) Improved antitumoral treatments